Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Search Results for "NRBO":

Results: 24

Quotes

NRBO Neurobo Pharmaceuticals Inc Stock - NASDAQ equities
Show all (1)

News

NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
By Investing.com

Phase 1 Clinical Trial Timelines Significantly AcceleratedTop-Line Data Readout from Single Ascending Dose Part 1 Now Expected in the Third Quarter of 2024First Patient Dosed in the Multiple Ascending...

NeuroBo completes enrollment for MASH drug trial
By Investing.com

CAMBRIDGE, Mass. - NeuroBo Pharmaceuticals, Inc. (NASDAQ: NASDAQ:NRBO) has announced the completion of the first part of its Phase 2a clinical trial for DA-1241, a novel treatment candidate for...

NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
By Investing.com

Received First Site Institutional Review Board (IRB) Approval  to Proceed With the Phase 1 Trial of DA-1726 in ObesityPhase 1 Trial of DA-1726 Expected to Dose First Patient in Second Quarter of...

Show all (23)
Results: 1

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 23

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 0

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email